{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:55:52Z","timestamp":1781740552121,"version":"3.54.5"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024570","name":"Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["72667"],"award-info":[{"award-number":["72667"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["00102578"],"award-info":[{"award-number":["00102578"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrep.2026.102578","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:20:39Z","timestamp":1776072039000},"page":"102578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transforming Duchenne muscular dystrophy therapy: The multifaceted role of extracellular vesicles and exosomes"],"prefix":"10.1016","volume":"46","author":[{"given":"Fatemeh","family":"Farzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Soltanmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Abolghasem","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratollah","family":"Zarghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7481-0896","authenticated-orcid":false,"given":"Effat","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JND-170255","article-title":"Muscular dystrophy with ribitol-phosphate deficiency: a novel post-translational mechanism in dystroglycanopathy","volume":"4","author":"Kanagawa","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0959-437X(03)00048-0","article-title":"Muscular dystrophies: genes to pathogenesis","volume":"13","author":"Dalkilic","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102578_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/qjmed\/hcm124","article-title":"Cardiac involvement in muscular dystrophies","volume":"101","author":"Beynon","year":"2008","journal-title":"Qjm"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCIMAGING.110.960740","article-title":"Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations","volume":"4","author":"Verhaert","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jcp.21895","article-title":"Cell based therapy for Duchenne muscular dystrophy","volume":"221","author":"Farini","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.bbrep.2026.102578_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/genes11080837","article-title":"Therapeutic strategies for Duchenne muscular dystrophy: an update","volume":"11","author":"Sun","year":"2020","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s41687-022-00500-8","article-title":"Patient life aspirations in the context of Duchenne Muscular Dystrophy: a mixed-methods case\u2013control study","volume":"6","author":"Schwartz","year":"2022","journal-title":"Journal of patient-reported outcomes"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102578_bib10","first-page":"Cd003725","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","volume":"2016","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrep.2026.102578_bib11","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S110163","article-title":"Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors","volume":"10","author":"Miyatake","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib12","first-page":"1202","article-title":"Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"11","author":"Nguyen","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbrep.2026.102578_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102034","article-title":"Exon 44 skipping in Duchenne muscular dystrophy: NS-089\/NCNP-02, a dual-targeting antisense oligonucleotide","volume":"34","author":"Watanabe","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajpath.2011.03.050","article-title":"Restoring dystrophin expression in Duchenne Muscular Dystrophy muscle: progress in exon skipping and stop Codon read through","volume":"179","author":"Hoffman","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrep.2026.102578_bib15","article-title":"Adeno-Associated virus (AAV)-Mediated gene therapy for Duchenne Muscular Dystrophy: the issue of transgene persistence","volume":"12","author":"Manini","year":"2021","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s13311-022-01197-9","article-title":"CRISPR-Cas9 gene therapy for Duchenne muscular dystrophy","volume":"19","author":"Mbakam","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbrep.2026.102578_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cobme.2024.100523","article-title":"Cell therapy for Duchenne muscular dystrophy using induced pluripotent stem cell-derived muscle stem cells and the potential of regenerative rehabilitation","volume":"30","author":"Takenaka-Ninagawa","year":"2024","journal-title":"Current Opinion in Biomedical Engineering"},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1261\/rna.653607","article-title":"Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications","volume":"13","author":"Aartsma-Rus","year":"2007","journal-title":"Rna"},{"issue":"s2","key":"10.1016\/j.bbrep.2026.102578_bib19","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.3233\/JND-210678","article-title":"Gene therapy for Duchenne Muscular Dystrophy","volume":"8","author":"Elangkovan","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.bbrep.2026.102578_bib20","first-page":"21","article-title":"Recent advancements in reducing the off-target effect of CRISPR-Cas9 genome editing","volume":"18","author":"Asmamaw Mengstie","year":"2024","journal-title":"Biologics"},{"key":"10.1016\/j.bbrep.2026.102578_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9628536","article-title":"Challenges and controversies in human mesenchymal stem cell therapy","volume":"2019","author":"Lukomska","year":"2019","journal-title":"Stem Cells Int"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"7","key":"10.1016\/j.bbrep.2026.102578_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"issue":"6478","key":"10.1016\/j.bbrep.2026.102578_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bbrep.2026.102578_bib25","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","article-title":"Exosomes as mediators of intercellular crosstalk in metabolism","volume":"33","author":"Isaac","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","article-title":"Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials","volume":"14","author":"Lotfy","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3324\/haematol.2017.183335","article-title":"Extracellular vesicles in the hematopoietic microenvironment","volume":"103","author":"Butler","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrep.2026.102578_bib29","first-page":"80","article-title":"Isolation and analysis methods of extracellular vesicles (EVs)","volume":"2","author":"Zhao","year":"2021","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102578_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mam.2017.09.006","article-title":"Emerging role of extracellular vesicles in musculoskeletal diseases","volume":"60","author":"Murphy","year":"2018","journal-title":"Mol Aspects Med"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102578_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/tra.12558","article-title":"The biology of extracellular microvesicles","volume":"19","author":"Sedgwick","year":"2018","journal-title":"Traffic"},{"issue":"9","key":"10.1016\/j.bbrep.2026.102578_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/ars.2019.7922","article-title":"Liquid biopsies: microvesicles in cardiovascular disease","volume":"33","author":"Badimon","year":"2020","journal-title":"Antioxid Redox Signal"},{"issue":"13","key":"10.1016\/j.bbrep.2026.102578_bib34","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-08-3860","article-title":"Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease","volume":"69","author":"Di Vizio","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2026.102578_bib35","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v5.33109","article-title":"Oncosomes - large and small: what are they, where they came from?","volume":"5","author":"Meehan","year":"2016","journal-title":"J. Extracell. Vesicles"},{"issue":"6478","key":"10.1016\/j.bbrep.2026.102578_bib36","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bbrep.2026.102578_bib37","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1158\/0008-5472.CAN-16-2942","article-title":"MYC mediates large oncosome-induced fibroblast reprogramming in prostate cancer","volume":"77","author":"Minciacchi","year":"2017","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102578_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4155\/tde-2023-0131","article-title":"Engineered exosomes: a promising vehicle in cancer therapy","volume":"14","author":"Pooresmaeil","year":"2023","journal-title":"Ther. Deliv."},{"issue":"14","key":"10.1016\/j.bbrep.2026.102578_bib38","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1039\/D4BM00558A","article-title":"A comprehensive review of engineered exosomes from preparation strategy to therapy applications","volume":"12","author":"Fan","year":"2024","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/14686996.2022.2133342","article-title":"Advances of engineered extracellular vesicles-based therapeutics strategy","volume":"23","author":"Komuro","year":"2022","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.bbrep.2026.102578_bib41","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib42","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.ymthe.2020.12.018","article-title":"Exosome-mediated improvement in membrane integrity and muscle function in dystrophic mice","volume":"29","author":"Leng","year":"2021","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102578_bib43","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.045559","article-title":"Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy","volume":"13","author":"Gartz","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbrep.2026.102578_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biomaterials.2018.04.055","article-title":"Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy","volume":"174","author":"Bier","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrep.2026.102578_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119826","article-title":"Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice","volume":"236","author":"Ran","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrep.2026.102578_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120435","article-title":"Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle","volume":"266","author":"Concei\u00e7\u00e3o","year":"2021","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102578_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005643","article-title":"Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation","volume":"4","author":"Di Santo","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102578_bib48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s12015-023-10517-1","article-title":"Conditioned Medium \u2013 is it an undervalued lab waste with the potential for osteoarthritis management?","volume":"19","author":"Rosochowicz","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.bbrep.2026.102578_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2616807","article-title":"Comparing the therapeutic potential of stem cells and their secretory products in regenerative medicine","volume":"2021","author":"Foo","year":"2021","journal-title":"Stem Cells Int"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","article-title":"Clinical applications of stem cell-derived exosomes","volume":"9","author":"Tan","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"24","key":"10.1016\/j.bbrep.2026.102578_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413454","article-title":"Modern approaches to acellular therapy in bone and dental regeneration","volume":"22","author":"Ivanov","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bbrep.2026.102578_bib54","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1007\/s00415-023-11796-x","article-title":"Duchenne muscular dystrophy: pathogenesis and promising therapies","volume":"270","author":"Chang","year":"2023","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s40478-023-01657-z","article-title":"Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells","volume":"11","author":"Cardone","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbrep.2026.102578_bib56","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00125-014-3337-2","article-title":"Exosomes participate in the alteration of muscle homeostasis during lipid-induced insulin resistance in mice","volume":"57","author":"Aswad","year":"2014","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.bbrep.2026.102578_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167811","article-title":"Characterization and functional analysis of extracellular vesicles and muscle-abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 myocytes and mdx mice","volume":"11","author":"Matsuzaka","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib58","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.stemcr.2018.01.023","article-title":"Exosome-mediated benefits of cell therapy in mouse and human models of Duchenne muscular dystrophy","volume":"10","author":"Aminzadeh","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrep.2026.102578_bib59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10741-016-9572-5","article-title":"MicroRNAs, heart failure, and aging: potential interactions with skeletal muscle","volume":"22","author":"Murach","year":"2017","journal-title":"Heart Fail. Rev."},{"issue":"17","key":"10.1016\/j.bbrep.2026.102578_bib60","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/hmg\/ddx212","article-title":"Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress","volume":"26","author":"Koutsoulidou","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102578_bib61","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/cdd.2013.62","article-title":"MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation","volume":"20","author":"Alexander","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrep.2026.102578_bib62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.matbio.2018.07.003","article-title":"Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis","volume":"74","author":"Zanotti","year":"2018","journal-title":"Matrix Biol."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102578_bib63","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050863","article-title":"HDAC inhibitors tune miRNAs in extracellular vesicles of dystrophic muscle\u2010resident mesenchymal cells","volume":"21","author":"Sandon\u00e0","year":"2020","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib64","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41401-020-0446-y","article-title":"Identification of critical molecular pathways involved in exosome-mediated improvement of cardiac function in a mouse model of muscular dystrophy","volume":"42","author":"Su","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"23","key":"10.1016\/j.bbrep.2026.102578_bib65","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/hmg\/ddab199","article-title":"Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy","volume":"30","author":"Gartz","year":"2021","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib66","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s44321-024-00049-7","article-title":"Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes","volume":"16","author":"Han","year":"2024","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/oli.2008.0161","article-title":"Therapeutic potential of splice-switching oligonucleotides","volume":"19","author":"Bauman","year":"2009","journal-title":"Oligonucleotides"},{"issue":"7","key":"10.1016\/j.bbrep.2026.102578_bib68","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ymthe.2022.05.023","article-title":"Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin gene","volume":"30","author":"Majeau","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib69","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-020-14957-y","article-title":"Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping","volume":"11","author":"Gee","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102578_bib70","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1007\/s11033-021-06360-7","article-title":"The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicine","volume":"48","author":"Rahimi","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib71","article-title":"Challenges and controversies in human mesenchymal stem cell therapy","volume":"2019","author":"Lukomska","year":"2019","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.bbrep.2026.102578_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mam.2017.09.006","article-title":"Emerging role of extracellular vesicles in musculoskeletal diseases","volume":"60","author":"Murphy","year":"2018","journal-title":"Mol. Aspect. Med."},{"issue":"15","key":"10.1016\/j.bbrep.2026.102578_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512457","article-title":"Amniotic membrane-derived stromal cells release extracellular vesicles that favor regeneration of dystrophic skeletal muscles","volume":"24","author":"Sandon\u00e0","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102578_bib74","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1159\/000514305","article-title":"Empowering muscle stem cells for the treatment of Duchenne muscular dystrophy","volume":"211","author":"Filippelli","year":"2022","journal-title":"Cells Tissues Organs"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12305","article-title":"Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases","volume":"12","author":"Li","year":"2023","journal-title":"J. Extracell. Vesicles"},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib76","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm1479","article-title":"Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors","volume":"12","author":"Minetti","year":"2006","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102578_bib79","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ymthe.2022.05.023","article-title":"Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin gene","volume":"30","author":"Majeau","year":"2022","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib77","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3390\/pharmaceutics14102236","article-title":"Extracellular vesicles as delivery vehicles for therapeutic nucleic acids in cancer gene therapy: progress and challenges","volume":"14","author":"Du","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.bbrep.2026.102578_bib78","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.3390\/ijms22116072","article-title":"CRISPR\/Cas9: principle, applications, and delivery through extracellular vesicles","volume":"22","author":"Horodecka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib80","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/ijms23031551","article-title":"Therapeutic application of extracellular vesicles-capsulated adeno-associated virus vector via nSMase2\/Smpd3, satellite, and immune cells in Duchenne muscular dystrophy","volume":"23","author":"Matsuzaka","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102578_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.matbio.2018.07.003","article-title":"Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis","volume":"74","author":"Zanotti","year":"2018","journal-title":"Matrix Biol."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib82","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41401-020-0446-y","article-title":"Identification of critical molecular pathways involved in exosome-mediated improvement of cardiac function in a mouse model of muscular dystrophy","volume":"42","author":"Su","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrep.2026.102578_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2024.102769","article-title":"Mesenchymal stem cell-derived exosomes as cell free nanotherapeutics and nanocarriers","volume":"61","author":"Abid","year":"2024","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102578_bib84","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93309","article-title":"MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin","volume":"2","author":"Heller","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib85","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.stemcr.2018.01.023","article-title":"Exosome-Mediated benefits of cell therapy in mouse and human models of Duchenne Muscular Dystrophy","volume":"10","author":"Aminzadeh","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib86","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008342","article-title":"Building muscle: molecular regulation of myogenesis","volume":"4","author":"Bentzinger","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.bbrep.2026.102578_bib88","first-page":"1","article-title":"Magnetic-field-driven targeting of exosomes modulates immune and metabolic changes in dystrophic muscle","author":"Villa","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102578_bib89","first-page":"2512","article-title":"Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles","volume":"112","author":"Dalli","year":"2008","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib90","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1096\/fj.11-182089","article-title":"Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow","volume":"26","author":"Dalli","year":"2012","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib91","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cjtee.2020.02.002","article-title":"Annexin A1 involved in the regulation of inflammation and cell signaling pathways","volume":"23","author":"Han","year":"2020","journal-title":"Chin. J. Traumatol. (Engl. Ed.)"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib92","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020342","article-title":"Delivery of oligonucleotides: efficiency with lipid conjugation and clinical outcome","volume":"14","author":"Tran","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib94","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","article-title":"Stability of endogenous and added RNA in blood specimens, serum, and plasma","volume":"48","author":"Tsui","year":"2002","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib95","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7150\/thno.5743","article-title":"Optimized siRNA-PEG conjugates for extended blood circulation and reduced urine excretion in mice","volume":"3","author":"Iversen","year":"2013","journal-title":"Theranostics"},{"issue":"14","key":"10.1016\/j.bbrep.2026.102578_bib96","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1093\/nar\/25.14.2730","article-title":"A new peptide vector for efficient delivery of oligonucleotides into mammalian cells","volume":"25","author":"Morris","year":"1997","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib97","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/ijms23020760","article-title":"Nanocarriers for delivery of oligonucleotides to the CNS","volume":"23","author":"Male","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib98","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/acsnano.3c08660","article-title":"Inhalable bottlebrush polymer bioconjugates as vectors for efficient pulmonary delivery of oligonucleotides","volume":"18","author":"Fang","year":"2023","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib99","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbrc.2004.12.118","article-title":"Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells","volume":"327","author":"Cooper","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.29.1.177","article-title":"Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension","volume":"29","author":"Phillips","year":"1997","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib101","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"7659","key":"10.1016\/j.bbrep.2026.102578_bib102","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib103","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.bbrep.2026.102578_bib104","doi-asserted-by":"crossref","DOI":"10.21037\/sci.2017.09.06","article-title":"Clinical potential of mesenchymal stem\/stromal cell-derived extracellular vesicles","volume":"4","author":"Giebel","year":"2017","journal-title":"Stem Cell Invest."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41565-017-0012-z","article-title":"Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression","volume":"13","author":"Pi","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib106","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7150\/thno.21945","article-title":"Exosome theranostics: biology and translational medicine","volume":"8","author":"He","year":"2018","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1472","article-title":"Nanotherapy for Duchenne muscular dystrophy","volume":"10","author":"Nance","year":"2018","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bbrep.2026.102578_bib108","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/j.nmd.2016.06.452","article-title":"Restoration of dystrophin expression and motor function in using exosomes-based non-immunogenic genetic therapy","volume":"26","author":"Saleem","year":"2016","journal-title":"Neuromuscul. Disord."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102578_bib133","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/JVI.74.7.3122-3129.2000","article-title":"An adeno-associated virus (AAV) initiator protein, Rep78, catalyzes the cleavage and ligation of single-stranded AAV ori DNA","volume":"74","author":"Smith","year":"2000","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib134","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/1061186X.2013.847099","article-title":"Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas","volume":"21","author":"Phan","year":"2013","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","article-title":"Immunogenicity of recombinant adeno-associated virus (AAV) vectors for gene transfer","volume":"37","author":"Arjomandnejad","year":"2023","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102578_bib136","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.7150\/thno.89380","article-title":"Understanding AAV vector immunogenicity: from particle to patient","volume":"14","author":"Dhungel","year":"2024","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib137","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib138","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s43556-024-00230-x","article-title":"Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications","volume":"5","author":"Zhao","year":"2024","journal-title":"Mol Biomed"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib139","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12951-018-0437-z","article-title":"Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells","volume":"17","author":"Sancho-Albero","year":"2019","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib141","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","article-title":"Engineered exosomes from different sources for cancer-targeted therapy","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrep.2026.102578_bib142","series-title":"Adeno-Associated Virus: Methods and Protocols","first-page":"141","article-title":"AAV-mediated liver-directed gene therapy","author":"Sands","year":"2011"},{"key":"10.1016\/j.bbrep.2026.102578_bib143","series-title":"Orally Administered Liposomal Formulations for Colon Targeted Drug Delivery","first-page":"138","author":"Hua","year":"2014"},{"issue":"9","key":"10.1016\/j.bbrep.2026.102578_bib144","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","article-title":"Long-term follow-up of the first in human intravascular delivery of AAV for gene transfer: Aav2-hfix16 for severe hemophilia B","volume":"28","author":"George","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrep.2026.102578_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115346","article-title":"Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads","volume":"211","author":"Leandro","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib146","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1038\/s41467-024-49332-8","article-title":"Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice","volume":"15","author":"Smith","year":"2024","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.bbrep.2026.102578_bib120","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1039\/D4NA00501E","article-title":"A comprehensive review of challenges and advances in exosome-based drug delivery systems","volume":"6","author":"Palakurthi","year":"2024","journal-title":"Nanoscale Adv."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib147","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/jphp.13329","article-title":"Scalable solvent-free production of liposomes","volume":"72","author":"Khadke","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib148","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.tibtech.2023.04.002","article-title":"Challenges in scaling up AAV-based gene therapy manufacturing","volume":"41","author":"Jiang","year":"2023","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib109","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12967-021-02863-w","article-title":"Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations","volume":"19","author":"Babaei","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1\u20132","key":"10.1016\/j.bbrep.2026.102578_bib110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clinbiochem.2013.10.020","article-title":"Comparison of serum exosome isolation methods for microRNA profiling","volume":"47","author":"Rekker","year":"2014","journal-title":"Clin. Biochem."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102578_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205496","article-title":"Harmonization of exosome isolation from culture supernatants for optimized proteomics analysis","volume":"13","author":"Abramowicz","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib112","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/btm2.10065","article-title":"Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell\u2010derived extracellular vesicles","volume":"2","author":"Patel","year":"2017","journal-title":"Bioeng. Transl. Med."},{"issue":"13","key":"10.1016\/j.bbrep.2026.102578_bib113","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/bloodadvances.2016003251","article-title":"Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis","volume":"1","author":"Umezu","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.bbrep.2026.102578_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.816698","article-title":"Biological features of extracellular vesicles and challenges","volume":"10","author":"Zeng","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102578_bib115","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3390\/nano11061481","article-title":"Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives","volume":"11","author":"Butreddy","year":"2021","journal-title":"Nanomaterials"},{"issue":"8","key":"10.1016\/j.bbrep.2026.102578_bib116","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.3390\/pharmaceutics15082042","article-title":"Exosome-based drug delivery: translation from bench to clinic","volume":"15","author":"Koh","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrep.2026.102578_bib117","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejps.2016.10.009","article-title":"Cell type-specific and common characteristics of exosomes derived from mouse cell lines: yield, physicochemical properties, and pharmacokinetics","volume":"96","author":"Charoenviriyakul","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"19","key":"10.1016\/j.bbrep.2026.102578_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911312","article-title":"Tracking of extracellular vesicles' biodistribution: new methods and approaches","volume":"23","author":"Aimaletdinov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102578_bib119","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fphar.2019.01368","article-title":"Sustained delivery system for stem cell-derived exosomes","volume":"10","author":"Riau","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102578_bib121","series-title":"Evaluation of batch-to-batch Variability and Efficacy of IPSC-Derived Mesenchymal Stromal Derived Extracellular Vesicles in Mitigating Osteoarthritis Associated Inflammation in Vitro","author":"Palam\u00e0","year":"2024"},{"issue":"11","key":"10.1016\/j.bbrep.2026.102578_bib122","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcyt.2020.04.040","article-title":"Challenges of manufacturing mesenchymal stromal cell\u2013derived extracellular vesicles in regenerative medicine","volume":"22","author":"Wiest","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbrep.2026.102578_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/jox15020055","article-title":"Stability dynamics of plant-based extracellular vesicles drug delivery","volume":"15","author":"Rawat","year":"2025","journal-title":"Journal of Xenobiotics"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102578_bib124","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12964-024-01510-3","article-title":"Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look","volume":"22","author":"Abbasi-Malati","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrep.2026.102578_bib125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcancer.2021.03.032","article-title":"Exosomes and extracellular vesicles: rethinking the essential values in cancer biology","volume":"74","author":"Yokoi","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrep.2026.102578_bib126","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12257-015-0781-x","article-title":"Influence of storage condition on exosome recovery","volume":"21","author":"Lee","year":"2016","journal-title":"Biotechnol. Bioproc. Eng."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102578_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/life12050697","article-title":"Impact of storage conditions on EV Integrity\/Surface markers and cargos","volume":"12","author":"Sivanantham","year":"2022","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib128","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/TA.0000000000003333","article-title":"Extracellular vesicle-associated procoagulant activity is highest the first 3 hours after trauma and thereafter declines substantially: a prospective observational pilot study","volume":"91","author":"Rognes","year":"2021","journal-title":"J. Trauma Acute Care Surg."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102578_bib129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14348\/molcells.2022.2033","article-title":"Manufacturing therapeutic exosomes: from bench to industry","volume":"45","author":"Ahn","year":"2022","journal-title":"Mol. Cells"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102578_bib130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4236\/cm.2020.113007","article-title":"Exosomes in clinical trial and their production in compliance with good manufacturing practice","volume":"32","author":"Chen","year":"2020","journal-title":"Tzu Chi Med. J."},{"key":"10.1016\/j.bbrep.2026.102578_bib131","series-title":"Extracellular Vesicles for Therapeutic and Diagnostic Applications","first-page":"523","article-title":"Chapter 18 - regulatory concerns for exosome- and other extracellular vesicle-based diagnostics and medicine products","author":"Bapat","year":"2025"},{"issue":"8","key":"10.1016\/j.bbrep.2026.102578_bib132","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13904","article-title":"Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Transl. Sci."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib149","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/jpm8040038","article-title":"Applications of CRISPR\/Cas9 for the treatment of Duchenne Muscular Dystrophy","volume":"8","author":"Lim","year":"2018","journal-title":"J. Personalized Med."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102578_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201700611","article-title":"Exosome\u2013liposome hybrid nanoparticles deliver CRISPR\/Cas9 system in MSCs","volume":"5","author":"Lin","year":"2018","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102578_bib151","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.7150\/thno.92133","article-title":"Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR\/Cas9 genome editing","volume":"14","author":"Dubey","year":"2024","journal-title":"Theranostics"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240558082600138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240558082600138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:48:09Z","timestamp":1781740089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240558082600138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":151,"alternative-id":["S240558082600138X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102578","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming Duchenne muscular dystrophy therapy: The multifaceted role of extracellular vesicles and exosomes","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102578"}}